Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Platforms & Performance

Gene therapy

Celerion’s rapidly expanding gene therapy focus supports our clients’ bioanalytical needs for drug development by utilizing our international laboratories and top-fight scientists

The Evolving Role of Gene Therapy in Drug Development

Gene therapy medicinal products (GTMPs) generally consist of a vector or delivery formulation/ system with an expressed therapeutic sequence including a genetic construct expressing therapeutic sequence or protein used to therapeutically target a genetic sequence for regulation, repair, addition or deletion.

Gene Therapy Product Support for

  • siRNA, RNA and DNA and Oligos
  • Encapsulated and naked plasmids and mRNAs
  • Viral vectors (adenovirus vectors (AdVs), adeno-associated virus vectors (AAVs), baculoviral vectors (BVs) and lentivirus vectors (LV))

Bioanalytical Strategy for Gene Therapy Product Development


Gene Therapy

Biomarkers for Immuno-Oncology

View White Paper

Gene Therapy

Unlocking the Value of Flow Cytometry

View White Paper